Get the Stockscreener App
4.58
15.66%
0.62
Pulmatrix Inc stock is traded at $4.58, with a volume of 34,973.
It is up +15.66% in the last 24 hours and down -6.15% over the past month.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
See More
Previous Close:
$3.96
Open:
$4.05
24h Volume:
34,973
Relative Volume:
3.15
Market Cap:
$16.73M
Revenue:
$11.68M
Net Income/Loss:
$-8.85M
P/E Ratio:
-1.9004
EPS:
-2.41
Net Cash Flow:
$-14.61M
1W Performance:
+12.25%
1M Performance:
-6.15%
6M Performance:
-42.61%
1Y Performance:
-21.03%
1-Day Range:
$4.05
$4.80
1-Week Range:
$3.92
$4.80
52-Week Range:
$3.9001
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Name
Pulmatrix Inc
Sector
Industry
Phone
(888) 355-4440
Address
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
4.58 | 14.46M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-18 | Initiated | H.C. Wainwright | Buy |
Pulmatrix Inc Stock (PULM) Latest News
Gains Report: Will Pulmatrix Inc stock maintain momentum in 2025Weekly Stock Recap & Capital Efficiency Focused Strategies - moha.gov.vn
Income Plays: What insider trading reveals about Pulmatrix Inc stockJuly 2025 Earnings & Weekly High Return Stock Forecasts - moha.gov.vn
Aug Gainers: How big funds are accumulating Vistra Corp 0V6 stockCPI Data & Safe Swing Trade Setup Alerts - BỘ NỘI VỤ
Pulmatrix Charts New Course Through Strategic Merger and Asset Divestment - AD HOC NEWS
How Pulmatrix Inc. stock benefits from strong dollar2025 Trading Recap & Intraday High Probability Alerts - Newser
How Pulmatrix Inc. (2PU) stock responds to bond marketJuly 2025 Technicals & Daily Stock Momentum Reports - Newser
Can Pulmatrix Inc. stock attract ESG capital inflowsMarket Performance Recap & AI Driven Stock Price Forecasts - Newser
Why institutional investors increase stakes in Pulmatrix Inc. (2PU) stockMarket Risk Analysis & High Return Stock Watch Alerts - Newser
How Pulmatrix Inc. (2PU) stock trades after earningsQuarterly Earnings Summary & Detailed Earnings Play Strategies - Newser
Why Pulmatrix Inc. (2PU) stock is a must watch tickerQuarterly Portfolio Report & Precise Entry and Exit Recommendations - Newser
Can Pulmatrix Inc. (2PU) stock deliver double digit returnsAnalyst Upgrade & Safe Entry Zone Tips - Newser
What market sentiment indicators show for Pulmatrix Inc. (2PU) stockWeekly Market Report & AI Forecasted Entry/Exit Points - Newser
Will Pulmatrix Inc. stock maintain dividend yieldMarket Sentiment Report & Weekly Setup with High ROI Potential - Newser
Is Pulmatrix Inc. (2PU) stock undervalued by metrics2025 AllTime Highs & High Accuracy Swing Trade Signals - Newser
Will Pulmatrix Inc. (2PU) stock see valuation expansionForecast Cut & Daily Profit Focused Screening - Newser
Is Pulmatrix Inc 2PU stock worth buying before Fed action2025 Market WrapUp & AI Enhanced Trading Signals - BỘ NỘI VỤ
Can Pulmatrix Inc. (2PU) stock retain market dominancePortfolio Value Report & Risk Controlled Swing Alerts - Newser
Is Pulmatrix Inc. stock a buy for dividend growthMarket Movement Recap & Community Driven Trade Alerts - Newser
Will Pulmatrix Inc. (2PU) stock benefit from Fed rate cutsWeekly Trend Summary & AI Based Trade Execution Alerts - Newser
Is Pulmatrix Inc. (2PU) stock among top earnings playsMarket Sentiment Review & Reliable Price Action Trade Plans - BỘ NỘI VỤ
KLTR Stock Analysis and ForecastEarnings Per Share Trends & AI-Driven Stock Forecast Models - earlytimes.in
Understanding Momentum Shifts in (PULM) - news.stocktradersdaily.com
Can Pulmatrix Inc. (2PU) stock double in coming yearsJuly 2025 Retail & Fast Entry High Yield Tips - newser.com
Can Pulmatrix Inc. stock outperform in 2025 bull marketMarket Activity Report & Free Fast Gain Swing Trade Alerts - newser.com
Why Pulmatrix Inc. (2PU) stock is a strong analyst pickPortfolio Performance Summary & Technical Confirmation Trade Alerts - newser.com
What consensus target says about Pulmatrix Inc. (2PU) stockQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
How Pulmatrix Inc. stock trades during market volatilityTrade Analysis Report & Expert Approved Momentum Ideas - newser.com
Trend analysis for Pulmatrix Inc. this weekPortfolio Gains Report & Technical Confirmation Trade Alerts - newser.com
Will Pulmatrix Inc. stock go up soon2025 Valuation Update & Real-Time Stock Movement Alerts - newser.com
Is Pulmatrix Inc. (2PU) stock prepared for digital transitionSell Signal & Real-Time Volume Trigger Notifications - newser.com
What recovery options are there for Pulmatrix Inc.Treasury Yields & Fast Entry High Yield Stock Tips - newser.com
Is Pulmatrix Inc. stock a smart buy before Fed meetingJuly 2025 Gainers & Pattern Based Trade Signal System - newser.com
What RSI levels show for Pulmatrix Inc. (2PU) stockJuly 2025 Opening Moves & Expert Verified Stock Movement Alerts - newser.com
Pulmatrix Inc Stock (PULM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):